NCT00236756View on ClinicalTrials.gov

A Study of the Efficacy and Safety of Topiramate as an add-on Therapy in the Treatment of Epilepsy Patients With Lennox-Gastaut Syndrome

PHASE3CompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

August 31, 1993

Study Completion Date

February 28, 2001

Conditions

EpilepsySeizures

Interventions

DRUG

topiramate

All Listed Sponsors

lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY